NASH Core Curriculum: A Comprehensive Online Resource Center

Download All
Expert faculty review strategies that are currently in late-stage clinical development and share their insights and perspectives on how they might fit into the treatment landscape.
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC

Emerging Management of NASH

Hear expert insights on emerging approaches for managing NASH, targeting both hepatic and extrahepatic manifestations.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: July 20, 2021 Expired: July 19, 2022

Hear expert perspectives on histologic and metabolic endpoints in NASH studies and how they may inform potential targets for oral, injectable, and combination NASH treatments.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Released: July 20, 2021

My take on how emerging drugs are measuring up.

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 17, 2021 Expired: September 16, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue